Skip to Content

University of Missouri School of Medicine studies effectiveness of Ivermectin and other drugs in mild COVID-19 cases


The University of Missouri School of Medicine Department of Emergency Medicine is participating in a national clinical study of three repurposed medications -- ivermectin, fluticasone and fluvoxamine. The study will look at the effectiveness of these medications in treating mild to moderate cases of COVID-19.

The study, titled “The Randomized Trial to Evaluate Efficacy of Repurposed Medications,” will look at how medicines already approved by the U.S. Food and Drug Administration for other purposes react in people diagnosed with COVID. Dr. Matthew Robinson, principal investigator and chair of the Department of Emergency Medicine said the goal is to find safe and effective treatments for COVID.

“There currently are no approved prescription medications that can be given easily at home to treat mild-to-moderate COVID early in its course to prevent worsening of symptoms and reduce the need for hospitalization," Robinson said.

Participants in the study must be 30 years and anyone in the United States can participate by enrolling online.

“We know the need for outpatient treatment will continue to grow as we see more cases, so this is a vital public health need,” Robinson said. 

Ivermectin has received both criticism and praise for its treatment against COVID. Lake Ozark Mayor Dennis Newberry posted on Facebook in August that he would take ivermectin to his friend in the hospital. The post has since been deleted.

In the same month, the FDA released a warning saying, "You are not a horse. You are not a cow. Seriously, y'all. Stop it."

Author Profile Photo

Hannah Falcon

Hannah joined the ABC 17 News Team from Houston, Texas, in June 2021. She graduated from Texas A&M University. She was editor of her school newspaper and interned with KPRC in Houston. Hannah also spent a semester in Washington, D.C., and loves political reporting.



  1. I love how people think it was just an animal med. lol Do some research and you find it has and still continues to be used in people. Hopefully when they do the study they will not set it up for failure.

  2. Isn’t it curious how quickly vaccines with inadequate testing were put into use, and how long it has taken for treatments with extensive histories of safety to even be looked at? $$$$

Leave a Reply

Skip to content